M06.3 Rheumatoid nodule

Name of the Condition

• Rheumatoid nodule

Summary

Rheumatoid nodule is a common extra-articular manifestation of rheumatoid arthritis (RA), characterized by firm, subcutaneous nodules typically found over bony prominences or pressure points. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. They are associated with severe, long-standing RA, particularly in patients with high rheumatoid factor or anti-CCP antibody levels. The exact pathogenesis involves dysregulated immune responses and fibroblast activation, leading to nodule formation. They may also develop at sites of trauma or injection.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules, often over elbows, fingers, or heels.
• Nodules may be painless or tender, especially if inflamed or ulcerated.
• Rarely, nodules can affect internal organs (e.g., lungs, heart), causing symptoms like cough or chest pain.
• Size and number vary, with larger nodules potentially impacting mobility or comfort.

Diagnosis

Diagnosis is primarily clinical, based on the appearance and location of nodules in a patient with RA. Biopsy may be performed if the diagnosis is uncertain or to rule out other conditions (e.g., infection, malignancy). Imaging (e.g., ultrasound) can confirm subcutaneous or deeper nodules. Correlation with RA history and serology supports the diagnosis.

Treatment Options

• Local care: Protect nodules from trauma; use padding or orthotics.
• Medical management: Optimize RA treatment (e.g., DMARDs, biologics) to reduce inflammation.
• Surgical intervention: Rarely required for painful, ulcerated, or functionally limiting nodules.
• Monitoring: Assess for changes in size, number, or associated symptoms.

Prognosis and Follow-Up

Rheumatoid nodules often persist but may fluctuate with RA disease activity. Prognosis depends on underlying RA control. Regular follow-up monitors nodule changes and screens for internal organ involvement. Nodule regression may occur with effective RA treatment, but new nodules can develop during flares.

Complications

• Ulceration or infection of overlying skin.
• Functional impairment if nodules affect joints or mobility.
• Rare internal organ involvement (e.g., pulmonary nodules, pericarditis).
• Psychosocial impact due to visible lesions.

Lifestyle & Prevention

• Protect nodules from pressure or injury (e.g., avoid leaning on elbows).
• Maintain RA control through medication adherence and lifestyle modifications.
• Regular skin checks for signs of ulceration or infection.
• Stress management to reduce RA flares, which may influence nodule activity.

When to Seek Professional Help

• Nodule becomes painful, red, or ulcerated.
• New or rapidly growing nodules develop.
• Systemic symptoms (e.g., fever, weight loss) accompany nodules.
• Nodules affect mobility or daily activities.

Tips for Medical Coders

Document the presence, location, and any associated symptoms or complications of rheumatoid nodules. Correlate with the patient’s RA diagnosis and disease activity. Ensure clear clinical justification for coding, as nodules are a key extra-articular manifestation of RA. Note any biopsy results or treatment interventions if performed.